340B

Jan 17, 2023
AHA 340B Hospital Members Urged to Submit Comments on HRSA’s Proposed Rule on the 340B Administrative Dispute Resolution Process, Model Comment Letter Available
Jan 10, 2023
Memorandum Opinion: Granting in Part, Denying In Part Plaintiffs Motion to Hold Unlawful and Remedy Defendants’ Past Underpayments of 340b Drugs
Jan 10, 2023
As drug prices continue to rise, the 340B drug pricing program continues to help hospitals expand access to comprehensive health services, including lifesaving prescription drugs for those in need who may not be able to afford them, writes AHA President and CEO Rick Pollack in the Wall Street…
Jan 10, 2023
The U.S. District Court for the District of Columbia today decided to allow the Department of Health and Human Services to propose an appropriate remedy for its past underpayments to hospitals participating in the 340B drug pricing program
Jan 10, 2023
For more than five years, the Department of Health and Human Services has unlawfully withheld vital funding from 340B hospitals that helps them provide a range of important benefits to their patients and communities. We are disappointed that the district court elected to extend this delay by…
Jan 10, 2023
The U.S. District Court for the District of Columbia today decided to allow the Department of Health and Human Services to propose an appropriate remedy for its past underpayments to hospitals participating in the 340B Drug Pricing Program.
Jan 10, 2023
For 30 years, the 340B drug pricing program has helped eligible hospitals offer a wide range of important programs and services that benefit patients and advance health within their communities.
Jan 6, 2023
The convening of the 118th Congress this week is a reminder of Washington’s highly-charged political environment.
Dec 20, 2022
The Wall Street Journal today published an article examining several aspects of the 340B Drug Pricing Program. Among other issues, the articles discusses 340B child sites, rural referral centers and charity care.